| Supported by NIH grant U01DE017018. This material was also supported by the North Florida/South Georgia Veterans Health System, Gainesville, FL. The OPPERA program also acknowledges resources specifically provided for this project by the respective host universities: University at Buffalo, University of Florida, University of Maryland-Baltimore, and University of North Carolina-Chapel Hill.
| Roger Fillingim and Gary Slade are consultants and equity stock holders, and William Maixner is a cofounder and equity stock holder in Algynomics, Inc., a company providing research services in personalized pain medication and diagnostics. Richard Ohrbach, Joel Greenspan, Charles Knott, Ronald Dubner, Eric Bair, Flora Mulkey and Rebecca Rothwell declare that they have no conflicts of interest. Portions of these data were presented at the 2010 Annual Scientific Meeting of the American Pain Society in Baltimore, MD.
| Supplementary data accompanying this article are available online at jpain.org and sciencedirect.com.
© 2011 American Pain Society. Publié par Elsevier Masson SAS. Tous droits réservés.